Florealis, a Startup Reykjavik company from the 2013 cohort, has secured its second round of seed financing of ISK 50 million (USD 395,000). The investor group behind the investment consists of experts from the pharmaceutical industry and angel investors. Previously, Florealis had secured another ISK 50 million in its first seed round.
Florealis develops high quality herbal medicine, aiming to be the leading provider of such products in the Nordics. The management team behind Florealis consists of individuals with varied backgrounds who all share a common passion for increasing professionalism and quality within the herbal medicine industry.
Florealis intends to use the capital for further development of its growing range of products and strengthen the sales and distribution network.
On behalf of Startup Reykjavik, I congratulate the founders and the management team with this delightful milestone.
For those interested, please see Kjarninn’s video coverage of Florealis (then Herberia) since last year with Kolbrún Hrafnkelsdóttir, the CEO of the company. The video is in Icelandic.
